These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4744861)

  • 1. Antineoplastic activity of lipid-soluble dialkyl esters of methotrexate.
    Johns DG; Farquhar D; Chabner BA; Wolpert MK; Adamson RH
    Experientia; 1973 Sep; 29(9):1104-5. PubMed ID: 4744861
    [No Abstract]   [Full Text] [Related]  

  • 2. Folic acid antagonists. Methotrexate analogs containing spurious amino acids. Dichlorohomofolic acid.
    Lee WW; Martinez AP; Goodman L
    J Med Chem; 1974 Mar; 17(3):326-30. PubMed ID: 4811228
    [No Abstract]   [Full Text] [Related]  

  • 3. Methotrexate analogs. 4.7-Methyl derivatives of methotrexate and dichloromethotrexate. A new synthesis and some biological studies.
    Rosowsky A; Chen KK
    J Med Chem; 1974 Dec; 17(12):1308-11. PubMed ID: 4214928
    [No Abstract]   [Full Text] [Related]  

  • 4. Analogues of methotrexate.
    Montgomery JA; Piper JR; Elliott RD; Temple C; Roberts EC; Shealy YF
    J Med Chem; 1979 Jul; 22(7):862-8. PubMed ID: 448685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The basis for the disparate sensitivity of L1210 leukemia and Walker 256 carcinoma to a new triazine folate antagonist.
    Skeel RT; Sawicki WL; Cashmore AR; Bertino JR
    Cancer Res; 1973 Nov; 33(11):2972-6. PubMed ID: 4748449
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of triazines as inhibitors of L1210 dihydrofolate reductase and of L1210 cells sensitive and resistant to methotrexate.
    Selassie CD; Strong CD; Hansch C; Delcamp TJ; Freisheim JH; Khwaja TA
    Cancer Res; 1986 Feb; 46(2):744-56. PubMed ID: 3940640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced forms of aminopterin and methotrexate in L1210 lymphoma.
    Makulu DR; Fölsch E
    J Natl Cancer Inst; 1977 Jul; 59(1):245-9. PubMed ID: 875056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies with a 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (DDMP)-resistant L1210 leukemia cell line without cross-resistance to methotrexate.
    Browman GP; Gorka C; Mehta C; Lazarus H; Abelson HT
    Biochem Pharmacol; 1980 Aug; 29(16):2241-5. PubMed ID: 7426028
    [No Abstract]   [Full Text] [Related]  

  • 9. Methotrexate analogs. 3. Synthesis and biological properties of some side-chain altered analogs.
    Chaykovsky M; Rosowsky A; Papathanasopoulos N; Chen KK; Modest EJ; Kisliuk RL; Gaumont Y
    J Med Chem; 1974 Nov; 17(11):1212-6. PubMed ID: 4213249
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent advances in the biochemical pharmacology of folic acid antagonists.
    Loo TL; Johns DG; Farquhar D
    Transplant Proc; 1973 Sep; 5(3):1161-5. PubMed ID: 4728815
    [No Abstract]   [Full Text] [Related]  

  • 11. Methotrexate analogues. 18. Enhancement of the antitumor effect of methotrexate and 3',5'-dichloromethotrexate by the use of lipid-soluble diesters.
    Rosowsky A; Yu CS
    J Med Chem; 1983 Oct; 26(10):1448-52. PubMed ID: 6620303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some biochemical and pharmacologic properties of amethopterin-albumin.
    Jacobs SA; D'Urso-Scott M; Bertino JR
    Ann N Y Acad Sci; 1971 Nov; 186():284-6. PubMed ID: 5289421
    [No Abstract]   [Full Text] [Related]  

  • 13. The interaction of carrier-bound methotrexate with L1210 cells.
    Chu BC; Whiteley JM
    Mol Pharmacol; 1980 May; 17(3):382-7. PubMed ID: 6156401
    [No Abstract]   [Full Text] [Related]  

  • 14. Deaza aalogues of amethopterin (methotrexate).
    Montgomery JA; Elliott RD; Straight SL; Temple C
    Ann N Y Acad Sci; 1971 Nov; 186():227-34. PubMed ID: 5002299
    [No Abstract]   [Full Text] [Related]  

  • 15. Synergy between 5,10-dideaza-5,6,7,8-tetrahydrofolic acid and methotrexate in mice bearing L1210 tumors.
    Ferguson K; Boschelli D; Hoffman P; Oronsky A; Whiteley J; Webber S; Galivan J; Freishiem J; Hynes J; Kerwar SS
    Cancer Chemother Pharmacol; 1989; 25(3):173-6. PubMed ID: 2598407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biologic evaluation of 7-hydroxymethotrexate, 7-methylaminopterin, and 7-methylmethotrexate.
    Farquhar D; Loo TL
    J Med Chem; 1972 May; 15(5):567-9. PubMed ID: 5035289
    [No Abstract]   [Full Text] [Related]  

  • 17. Growth inhibitory, transport and biochemical properties of the gamma-glutamyl and gamma-aspartyl peptides of methotrexate in L1210 leukemia cells in vitro.
    Sirotnak FM; Chello PL; Piper JR; Montgomery JA
    Biochem Pharmacol; 1978; 27(14):1821-5. PubMed ID: 708463
    [No Abstract]   [Full Text] [Related]  

  • 18. A fluorescent derivative of methotrexate as an intracellular marker for dihydrofolate reductase in L1210 cells.
    Henderson GB; Russell A; Whiteley JM
    Arch Biochem Biophys; 1980 Jun; 202(1):29-34. PubMed ID: 6772112
    [No Abstract]   [Full Text] [Related]  

  • 19. On the poor correlation between the inhibition by methotrexate of dihydrofolate reductase and of deoxynucleoside incorporation into DNA.
    Roberts D; Wodinsky I
    Cancer Res; 1968 Oct; 28(10):1955-62. PubMed ID: 5696929
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of dihydrofolate reductase by methotrexate: a new look at an old problem.
    Fan CC; Vitols KS; Huennekens FM
    Adv Enzyme Regul; 1980; 18():41-52. PubMed ID: 6934688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.